Financials
- Market Capitalization 1.79 B
- Employee 260
- Founded 1997
- CEO N/A
- Website www.xencor.com
- Headquarter Delaware, United States
- FIGI BBG0026ZG4W0
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-12.35
ratio cours/chiffre d'affaires
9.05
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2004 | VIR Vir Biotechnology, Inc. - Common Stock | 10.67 USD | +0.57% | -6.81% | -0.37% | +78.43% | 1.81 B USD | ||
| 2010 | MESO Mesoblast Limited - American Depositary Shares | 13.83 USD | -0.50% | -1.85% | -6.55% | -22.30% | 1.79 B USD | ||
| 2022 | TRVI Trevi Therapeutics, Inc. - Common Stock | 12.45 USD | +1.30% | -5.82% | -21.60% | +20.87% | 1.77 B USD | ||
| 2026 | SRPT Sarepta Therapeutics, Inc. - Common Stock | 16.60 USD | +0.55% | -5.57% | -20.23% | -23.71% | 1.75 B USD |